Bio-Rad Laboratories, Inc. Class A Common Stock vs Transocean Ltd — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Transocean Ltd trades at $5.31 (market cap $5.94B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is the larger of the two by market cap. Which is the better fit depends on your goals.
| BIO | RIG | |
|---|---|---|
Market Cap | $8.02B | $5.94B |
Sector | Health | Technology |
52-Week High | $339.75 | $7.58 |
52-Week Low | $241.71 | $2.55 |
Enterprise Value | $7.84B | $10.89B |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →